{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:26:50Z","timestamp":1782354410211,"version":"3.54.5"},"reference-count":37,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Slimbiotics GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Recent research has highlighted the potential of postbiotics for addressing obesity and associated metabolic disorders. In this randomized, double-blind clinical trial, the efficacy of a postbiotic product in managing overweight and associated parameters was assessed. Methods: Sixty individuals were randomized into two groups: one group (n = 30) received the Postbiotic (heat-killed L. fermentum strain K8-Lb1) and the other (n = 30) a Placebo control. Body weight, waist circumference, body composition, vital signs, blood biomarkers and questionnaires for quality of life, eating behavior, eating control and gastrointestinal symptoms were assessed. Results: After a 12-week intervention, body fat mass (primary parameter) was significantly (p = 0.016) reduced in the Postbiotic group (98.15 \u00b1 3.32% of baseline) compared to the Placebo group (100.41 \u00b1 3.39%). In line with this, body weight (p = 0.047) and waist circumference (p = 0.034) were significantly reduced and visceral fat tended to be reduced (p = 0.053). Accordingly, the Postbiotic group tended (p = 0.066) to feel more in control of their body weight. Despite weight loss, muscle mass tended (p = 0.062) to increase. ALT, AST and GGT tended to be reduced, which may indicate an improvement in liver steatosis. Estimated average glucose (eAG) differed significantly between the groups in individuals with normal fasting glucose levels. The ability to concentrate significantly (p = 0.014) improved. Conclusions: Under an ad libitum diet, the postbiotic L. fermentum strain K8-Lb1 reduced body fat mass, body weight, and waist circumference, improved the ability to concentrate, and showed a trend towards an increase in muscle mass. The results of this pilot trial need confirmation by a pivotal trial.<\/jats:p>","DOI":"10.3390\/nu18081174","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:41:18Z","timestamp":1775648478000},"page":"1174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Limosilactobacillus fermentum K8-Lb1 Postbiotic on Weight Management and Metabolic Health Outcomes"],"prefix":"10.3390","volume":"18","author":[{"given":"Ekaterina","family":"Papazova","sequence":"first","affiliation":[{"name":"Clinical Research Center Kiel, Kiel Center of Innovation and Technology, Schauenburgerstra\u00dfe 116, D-24118 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Mitschke","sequence":"additional","affiliation":[{"name":"Citruslabs, Las Vegas, NV 89118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Laue","sequence":"additional","affiliation":[{"name":"Clinical Research Center Kiel, Kiel Center of Innovation and Technology, Schauenburgerstra\u00dfe 116, D-24118 Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schrezenmeir","sequence":"additional","affiliation":[{"name":"Clinical Research Center Kiel, Kiel Center of Innovation and Technology, Schauenburgerstra\u00dfe 116, D-24118 Kiel, Germany"},{"name":"University Medicine, Johannes-Gutenberg University, D-55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"ref_1","unstructured":"CDC (2024, March 08). Obesity and Severe Obesity Prevalence in Adults: United States, August 2021\u2013August 2023 Obesity is a Common, Serious, and Costly Disease, Available online: https:\/\/www.govinfo.gov\/content\/pkg\/GOVPUB-HE20_6200-PURL-gpo234106\/pdf\/GOVPUB-HE20_6200-PURL-gpo234106.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09581596.2024.2333407","article-title":"The economic burden of obesity in 2024: A cost analysis using the value of a statistical life","volume":"34","author":"Sweis","year":"2024","journal-title":"Crit. Public Health"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ward, Z.J., Bleich, S.N., Long, M.W., and Gortmaker, S.L. (2021). Association of body mass index with health care expenditures in the United States by age and sex. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0247307"},{"key":"ref_4","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (2024, March 08). Overweight; Obesity Statistics, Available online: https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/overweight-obesity."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3748\/wjg.v27.i25.3837","article-title":"Gut microbiota in obesity","volume":"27","author":"Liu","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_6","first-page":"e879151","article-title":"Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?","volume":"2012","author":"Harris","year":"2012","journal-title":"J. Obes."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12934-020-01426-w","article-title":"Postbiotics-parabiotics: The new horizons in microbial biotherapy and functional foods","volume":"19","author":"Nataraj","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Le\u00f3n Aguilera, X.E., Manzano, A., Pirela, D., and Berm\u00fadez, V. (2022). Probiotics and Gut Microbiota in Obesity: Myths and Realities of a New Health Revolution. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081282"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pizarroso, N.A., Fuci\u00f1os, P., Gon\u00e7alves, C., Pastrana, L., and Amado, I.R. (2021). A review on the role of food-derived bioactive molecules and the microbiota\u2013gut\u2013brain axis in satiety regulation. Nutrients, 13.","DOI":"10.3390\/nu13020632"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10311-019-00896-8","article-title":"Probiotics for dietary management of non-alcoholic fatty liver disease","volume":"17","author":"Elshaghabee","year":"2019","journal-title":"Environ. Chem. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113138","DOI":"10.1016\/j.biopha.2022.113138","article-title":"Postbiotics as potential new therapeutic agents for metabolic disorders management","volume":"153","author":"Bourebaba","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3920\/BM2010.0019","article-title":"Identification and characterization of lactobacilli isolated from Kimere, a spontaneously fermented pearl millet dough from Mbeere, Kenya (East Africa)","volume":"1","author":"Njeru","year":"2010","journal-title":"Benef. Microbes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.imbio.2013.10.005","article-title":"Molecular identification of potential Th1\/Th2 responses-modulating bacterial genes using suppression subtractive DNA hybridization","volume":"219","author":"Ghadimi","year":"2014","journal-title":"Immunobiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"756S","DOI":"10.1093\/jn\/137.3.756S","article-title":"Molecular and cellular basis of microflora-host interactions","volume":"137","author":"Winkler","year":"2007","journal-title":"J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.imbio.2010.10.008","article-title":"PPAR\u03b3-dependent peptidoglycan recognition protein 3 (PGlyRP3) expression regulates proinflammatory cytokines by microbial and dietary fatty acids","volume":"216","author":"Zenhom","year":"2011","journal-title":"Immunobiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.imbio.2011.10.013","article-title":"Peptidoglycan recognition protein 3 (PglyRP3) has an anti-inflammatory role in intestinal epithelial cells","volume":"217","author":"Zenhom","year":"2012","journal-title":"Immunobiology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Williams, L., Alshehri, A., Robichaud, B., Cudmore, A., and Gagnon, J. (2020). The role of the bacterial muramyl dipeptide in the regulation of GLP-1 and glycemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155252"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Al Ebrahim, R.N., Alekseeva, M.G., Bazhenov, S.V., Fomin, V.V., Mavletova, D.A., Nesterov, A.A., Poluektova, E.U., Danilenko, V.N., and Manukhov, I.V. (2024). ClpL chaperone as a possible component of the disaggregase activity of Limosilactobacillus fermentum U-21. Biology, 13.","DOI":"10.20944\/preprints202405.1769.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41366-019-0515-9","article-title":"Commensal Hafnia alvei strain reduces food intake and fat mass in obese mice\u2014A new potential probiotic for appetite and body weight management","volume":"44","author":"Legrand","year":"2020","journal-title":"Int. J. Obes."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"D\u00e9chelotte, P., Breton, J., Trotin-Picolo, C., Grube, B., Erlenbeck, C., Bothe, G., Fetissov, S.O., and Lambert, G. (2021). The probiotic strain H. alvei HA4597\u00ae improves weight loss in overweight subjects under moderate hypocaloric diet: A proof-of-concept, multicenter randomized, double-blind placebo-controlled study. Nutrients, 13.","DOI":"10.3390\/nu13061902"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Laue, C., Papazova, E., Pannenbeckers, A., and Schrezenmeir, J. (2023). Effect of a probiotic and a synbiotic on body fat mass, body weight and traits of metabolic syndrome in individuals with abdominal overweight: A human, double-blind, randomised, controlled clinical study. Nutrients, 15.","DOI":"10.3390\/nu15133039"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.ijo.0801442","article-title":"Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study","volume":"24","author":"Karlsson","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_23","unstructured":"State of New Hampshire Employee Assistance Program (2024, March 08). Perceived Stress Scale, Available online: https:\/\/www.das.nh.gov\/wellness\/docs\/percieved%20stress%20scale.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-3999(93)90120-5","article-title":"Development of the perceived stress questionnaire: A new tool for psychosomatic research","volume":"37","author":"Levenstein","year":"1993","journal-title":"J. Psychosom. Res."},{"key":"ref_25","unstructured":"(2024, March 08). GAD7 Anxiety Test Questionnaire. Available online: https:\/\/patient.info\/doctor\/generalised-anxiety-disorder-assessment-gad-7."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population","volume":"46","author":"Decker","year":"2008","journal-title":"Med. Care"},{"key":"ref_27","unstructured":"EFSA (2018). Panel on Additives Products or Substances used in Animal Feed (FEEDAP) Guidance on the characterisation of microorganisms used as feed additives or as production organisms. Efsa J., 16, 5206."},{"key":"ref_28","unstructured":"(2010). Milk and Milk Products\u2014Determination of the Minimal Inhibitory Concentration (MIC) of Antibiotics Applicable to Bifidobacteria and Non-Enterococcal Lactic Acid Bacteria (LAB) (Standard No. IDF 223:2010\/ISO 10932 I: 2010)."},{"key":"ref_29","first-page":"21","article-title":"Power comparisons of Shapiro-Wilk, Kolmogorov-Smirnov, Lilliefors and Anderson-Darling tests","volume":"2","author":"Razali","year":"2011","journal-title":"J. Stat. Model. Anal."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: A systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4093\/dmj.2025.0242","article-title":"Exploring the side effects of GLP-1 receptor agonist: To ensure its optimal positioning","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaophthalmol.2025.1455","article-title":"Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration","volume":"143","author":"Shor","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.3350\/cmh.2022.0362","article-title":"Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments","volume":"29","author":"Ahn","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000527595","article-title":"Obesity-induced hepatic steatosis is partly mediated by visceral fat accumulation in subjects with overweight\/obesity: A cross-sectional study","volume":"16","author":"Liu","year":"2023","journal-title":"Obes. Facts"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/neurosci3030027","article-title":"Obesity and neurocognitive performance of memory, attention, and executive function","volume":"3","author":"Lentoor","year":"2022","journal-title":"NeuroSci"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1186\/s12967-025-06927-z","article-title":"Postbiotics as a novel intervention for obesity management and improving metabolic parameters: A systematic review and meta-analysis of animal studies","volume":"23","author":"Nazarinejad","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12986-025-01037-5","article-title":"The effect of postbiotics supplementation on obesity and metabolic health: A systematic review and meta-analysis of randomized control trials","volume":"22","author":"Li","year":"2025","journal-title":"Nutr. Metab."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/8\/1174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:49:08Z","timestamp":1775648948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/8\/1174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["nu18081174"],"URL":"https:\/\/doi.org\/10.3390\/nu18081174","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}